Estrogen plays an important role in regulating testicular Sertoli cell number. Furthermore, S-phase kinase-associated protein 2 (SKP2) plays a central role in mammalian cell cycle progression. The objective of this study was to determine whether 17beta-estradiol can regulate the expression of SKP2, and ultimately the Sertoli , the cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) and extracellular signal-regulated kinase (ERK1/2) pathway. When cultured immature boar Sertoli cells were treated with 17 beta-estradiol, a time-dependent increase in SKP2 mRNA and protein level was observed by Real time PCR and western blot, and beta-estradiol activity peaked at 30 min. Treatment with ICI182780 and reduced 17 beta-estradiol-induced expression of SKP2 and proliferating cell nuclear antigen (PCNA), while increasing the protein concentration of p27 kip1. However, the effect of on these parameters was lower than that of ICI182780 and Forskolin had a similar effect as beta-estradiol on the expression of SKP2, PCNA and p27 kip1. Rp-cAMP, H-89 and U0126 treatment reduced 17 beta-estradiol-induced changes, while H-89 also inhibited ERK1/2 activation. Therefore, beta-estradiol mainly regulates SKP2 mRNA-cAMP-PKA and ERK1/2 activation. SKP2 and PCNA expression were positively correlated, while increased SKP2 expression likely resulted in p27 kip1 degradation.